The “Liquid Biopsy”: the Role of Circulating DNA and RNA in Central Nervous System Tumors

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Current Neurology and Neuroscience Reports

• Publication date

  2016-02-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11910-016-0629-6PMID 26838352PMCID PMC8423147
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord

  2015cited by this paper
• Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer.

  2015cited by this paper
• Brain tumor mutations detected in cerebral spinal fluid.

  2015cited by this paper
• Identification of microRNAs as novel biomarkers for glioma detection: a meta-analysis based on 11 articles.

  2015cited by this paper
• Committee Opinion Summary No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.

  2015cited by this paper
• The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids

  2015cited by this paper
• Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.

  2015cited by this paper
• 2905 Genomic characterization of brain metastases and paired primary tumors reveals branched evolution and potential therapeutic targets

  2015cited by this paper
• Hematogenous dissemination of glioblastoma multiforme

  2014cited by this paper
• MicroRNAs as Potential Biomarkers for Diagnosing Cancers of Central Nervous System: a Meta-analysis

  2014cited by this paper
• Cancer: Hematogenous dissemination of glioblastoma multiforme

  2014cited by this paper
• Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay.

  2014cited by this paper
• Abstract 5606: Detection of circulating tumor DNA in early and late stage human malignancies

  2014cited by this paper
• Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA.

  2014cited by this paper
• Brain tumor cells in circulation are enriched for mesenchymal gene expression.

  2014cited by this paper
• Circulating tumour cells and cell-free DNA as tools for managing breast cancer

  2013cited by this paper
• Liquid biopsy: monitoring cancer-genetics in the blood

  2013cited by this paper
• BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles

  2013cited by this paper
• An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

  2013cited by this paper
• Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing.

  2013cited by this paper
• Circulating tumor cells: liquid biopsy of cancer.

  2013cited by this paper
• Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients.

  2013cited by this paper
• Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma.

  2012cited by this paper
• Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

  2012cited by this paper
• Detection of low frequency FGFR3 mutations in the urine of bladder cancer patients using next-generation deep sequencing

  2012cited by this paper
• MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity.

  2012cited by this paper
• Cell-free nucleic acids as biomarkers in cancer patients

  2011cited by this paper
• Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system.

  2011cited by this paper
• Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades.

  2010cited by this paper
• Quantitative detection of multiple gene promoter hypermethylation in tumor tissue, serum, and cerebrospinal fluid predicts prognosis of malignant gliomas.

  2010cited by this paper
• Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

  2010cited by this paper
• Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue.

  2009cited by this paper
• Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer

  2009cited by this paper
• Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma

  2008cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• Free circulating mRNA in plasma from breast cancer patients and clinical outcome.

  2008cited by this paper
• Circulating DNA

  2008cited by this paper
• Detection of microRNA Expression in Human Peripheral Blood Microvesicles

  2008cited by this paper
• Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

  2008cited by this paper
• The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells

  2005cited by this paper
• Detection and quantification of mutations in the plasma of patients with colorectal tumors.

  2005cited by this paper
• Molecular Detection of APC, K-ras, and p53 Mutations in the Serum of Colorectal Cancer Patients as Circulating Biomarkers

  2004cited by this paper
• Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

  2004cited by this paper
• Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics.

  2004cited by this paper
• Downloaded from jdr.sagepub.com at PENNSYLVANIA STATE UNIV on February 23, 2013 For personal use only. No other uses without permission. International and American Associations for Dental ResearchRAPID COMMUNICATION Clinical

  2004cited by this paper
• O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.

  2003cited by this paper
• Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients.

  2003cited by this paper
• Detection of Amplifiable Messenger RNA in the Serum of Patients with Lung Cancer

  2001cited by this paper
• Microsatellite alterations plasma DNA of primary breast cancer patients.

  2000cited by this paper
• Telomerase RNA as a detection marker in the serum of breast cancer patients.

  2000cited by this paper
• Detection of tumor messenger RNA in the serum of patients with malignant melanoma.

  1999cited by this paper
• Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma.

  1999cited by this paper
• Detection and characterization of carcinoma cells in the blood.

  1998cited by this paper
• Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

  1995cited by this paper
• Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering from neurological complications associated with chicken pox or herpes zoster

  1991cited by this paper
• Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis.

  1990influential reference
• Free DNA in the serum of cancer patients and the effect of therapy.

  1977cited by this paper
• Les acides nucleiques du plasma sanguin chez l' homme

  1948cited by this paper
• [Not Available].

  1948cited by this paper

• Data‐Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain

  2026cites this paper
• Profiling extracellular vesicles from cerebrospinal fluid for classification of intradural spinal tumors

  2025cites this paper
• Data-driven feedback augments ultrasound nanotheranostics in brain tumors

  2025cites this paper
• Clinical Features, Molecular Biology, and the Metastatic Microenvironment in Lung Cancer Brain Metastases: Implications for Treatment Decisions

  2025cites this paper
• Role of Liquid Biopsy for Early Detection, Prognosis, and Therapeutic Monitoring of Hepatocellular Carcinoma

  2025cites this paper
• Liquid biopsy for microbiome profiling through nucleotide analysis.

  2025cites this paper
• Adaptive cohort design and LAT1 expression scale: study protocol for a Phase 2a trial of QBS72S in breast cancer brain metastases

  2025cites this paper
• Novel multiparametric bulk and single extracellular vesicle pipeline for adipose cell-specific biomarker discovery in paired human biospecimens

  2024cites this paper
• Application of Circulating Tumor DNA in the Auxiliary Diagnosis and Prognosis Prediction of Glioma

  2024cites this paper
• Ultrasound mediated blood-brain barrier opening increases brain tumor biomarkers: A review of preclinical and clinical trials

  2024cites this paper
• Targeted liquid biopsy for brain tumors

  2024cites this paper
• Diagnostic and Prognostic Value of Circulating DNA Fragments in Glioblastoma Multiforme Patients

  2024cites this paper
• Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-Analysis

  2023cites this paper
• Circulating tumor DNA: current implementation issues and future challenges for clinical utility

  2023cites this paper
• Expression of circulating tumour cells in oral squamous cell carcinoma: An ex vivo pilot study

  2023cites this paper
• First-in-human prospective trial of sonobiopsy in high-grade glioma patients using neuronavigation-guided focused ultrasound

  2023cites this paper
• First-in-human prospective trial of sonobiopsy in glioblastoma patients using neuronavigation-guided focused ultrasound

  2023cites this paper
• Characterization of the Targeting Accuracy of a Neuronavigation-Guided Transcranial FUS System In Vitro, In Vivo, and In Silico

  2022cites this paper
• Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA

  2022cites this paper
• Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases—From Biology to Clinical Utility

  2022cites this paper
• Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)

  2022cites this paper
• Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs

  2022cites this paper
• Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028)

  2022cites this paper
• Comparison of the diagnostic value of liquid biopsy in leptomeningeal metastases: A systematic review and meta-analysis

  2022cites this paper
• In Vitro Analysis of Biological Activity of Circulating Cell-Free DNA Isolated from Blood Plasma of Schizophrenic Patients and Healthy Controls

  2022cites this paper
• Detection of gene mutations and gene–gene fusions in circulating cell‐free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis

  2021cites this paper
• Methylation of the Sclerostin Gene in Serum Free DNA: A New Bone Biomarker?

  2021cites this paper
• Methylation of the Sclerostin (SOST) Gene in Serum Free DNA: A New Bone Biomarker?

  2020cites this paper
• Limited utility of qPCR-based detection of tumor-specific circulating mRNAs in whole blood from clear cell renal cell carcinoma patients

  2020cites this paper
• Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors

  2020influential citation
• Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors

  2020influential citation
• Evaluation of neutrophil extracellular traps as the circulating marker for patients with acute coronary syndrome and acute ischemic stroke

  2020cites this paper
• Liquid biopsies for the diagnosis and surveillance of primary pediatric central nervous system tumors: a review for practicing neurosurgeons.

  2020cites this paper
• A liquid biopsy platform for detecting gene-gene fusions as glioma diagnostic biomarkers and drug targets

  2020cites this paper
• Cerebrospinal fluid biomarkers for brain tumor detection: clinical roles and current progress.

  2020cites this paper
• Feasibility and safety of focused ultrasound-enabled liquid biopsy in the brain of a porcine model

  2020cites this paper
• Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors

  2020cites this paper
• Creative and Innovative Methods and Techniques for the Challenges in the Management of Adult Craniopharyngioma.

  2020cites this paper
• La biopsia líquida en el diagnóstico y monitoreo de pacientes oncológicos: oportunidades y retos en Latinoamérica

  2020cites this paper
• Liquid biopsy in central nervous system tumors: the potential roles of circulating miRNA and exosomes.

  2020cites this paper
• Significance of liquid biopsy in glioblastoma - A review.

  2019cites this paper
• New Frontiers in Diagnosis and Therapy of Circulating Tumor Markers in Cerebrospinal Fluid In Vitro and In Vivo

  2019cites this paper
• Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications

  2019cites this paper
• Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies

  2019cites this paper
• Application of flow systems in laboratory diagnostics for the integral evaluation of the hemostatic system

  2018cites this paper
• Cell-free DNA as a biomarker in stroke: Current status, problems and perspectives

  2018cites this paper
• Liquid Biopsy in Pediatric Brain Cancers: A Theragnostic Opportunity

  2018cites this paper
• Quantification of cell-free DNA in blood plasma and DNA damage degree in lymphocytes to evaluate dysregulation of apoptosis in schizophrenia patients.

  2017cites this paper
• Cell-Free Circulating Epigenomic Signatures: Non-Invasive Biomarker for Cardiovascular and Other Age-Related Chronic Diseases.

  2017cites this paper
• A pilot study on the use of cerebrospinal fluid cell-free DNA in intramedullary spinal ependymoma

  2017cites this paper
• Current and emerging biomarkers in tumors of the central nervous system: Possible diagnostic, prognostic and therapeutic applications.

  2017cites this paper
• Further the liquid biopsy: Gathering pieces of the puzzle of genometastasis theory

  2017cites this paper
• Diagnostic muscle biopsy: is it still needed on the way to a liquid muscle pathology?

  2016cites this paper